These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19325)

  • 21. Influence of neuroleptics on the binding of met-enkephalin, morphine and dihydromorphine to synaptosome-enriched fractions of rat brain.
    Somoza E
    Neuropharmacology; 1978 Aug; 17(8):577-81. PubMed ID: 29252
    [No Abstract]   [Full Text] [Related]  

  • 22. Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors.
    Handa BK; Land AC; Lord JA; Morgan BA; Rance MJ; Smith CF
    Eur J Pharmacol; 1981 Apr; 70(4):531-40. PubMed ID: 6263640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide.
    Simantov R; Childers SR; Snyder SH
    Eur J Pharmacol; 1978 Feb; 47(3):319-31. PubMed ID: 204498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins.
    Lazarus LH; Ling N; Guillemin R
    Proc Natl Acad Sci U S A; 1976 Jun; 73(6):2156-9. PubMed ID: 1064883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similarity between mu-opioid receptors in mouse vas deferens and guinea-pig ileum.
    Goodall J; Hughes IE; Mackay D
    Br J Pharmacol; 1985 May; 85(1):277-83. PubMed ID: 2992651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opiate receptors and opioid peptides: an overview.
    Simon EJ
    Ann N Y Acad Sci; 1982; 398():327-39. PubMed ID: 6297357
    [No Abstract]   [Full Text] [Related]  

  • 27. Opioid peptides and opiates differ in receptor selectivity.
    Terenius L
    Psychoneuroendocrinology; 1977; 2(1):53-8. PubMed ID: 198833
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of binding of [3H]-methionine-enkephalin, [3H]-naltrexone and [3H]-dihydromorphine in the mouse vas deferens and the myenteric plexus and brain of the ginea pig.
    Leslie FM; Kosterlitz HW
    Eur J Pharmacol; 1979 Jul; 56(4):379-83. PubMed ID: 477732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mode of action of endogenous opiate peptides.
    Klee WA; Nirenberg M
    Nature; 1976 Oct; 263(5578):609-12. PubMed ID: 185523
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors.
    Kosterlitz HW; Lord JA; Paterson SJ; Waterfield AA
    Br J Pharmacol; 1980 Feb; 68(2):333-42. PubMed ID: 6101980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 32. [D-Pen2, L-Cys5]enkephalinamide and[D-Pen2, D-Cys5] enkephalinamide, conformationally constrained cyclic enkephalinamide analogs with delta receptor specificity.
    Mosberg HI; Hurst R; Hruby VJ; Galligan JJ; Burks TF; Gee K; Yamamura HI
    Biochem Biophys Res Commun; 1982 May; 106(2):506-12. PubMed ID: 6285922
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides.
    Chang KJ; Cooper BR; Hazum E; Cuatrecasas P
    Mol Pharmacol; 1979 Jul; 16(1):91-104. PubMed ID: 225656
    [No Abstract]   [Full Text] [Related]  

  • 34. Opiate binding sites and endogenous opioids in Bufo viridis oocytes.
    Bakalkin GYa ; Yakovleva TV; Nikitina LA; Korobov NV; Vinogradov VA; Titov MI
    Biochem Biophys Res Commun; 1983 Dec; 117(3):718-24. PubMed ID: 6320813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphine tolerance is associated with elevated levels of an uncharacterized endorphin (peak B) in mouse brain with no change in 3H-dihydromorphine binding.
    Lipman JJ; Miller BE; Karkara S; Winfield RC; North WC; Byrne WL
    Life Sci; 1983; 33 Suppl 1():373-6. PubMed ID: 6319893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the receptor binding characteristics of opiate agonists interacting with mu- or kappa-receptors.
    Kosterlitz HW; Leslie FM
    Br J Pharmacol; 1978 Dec; 64(4):607-14. PubMed ID: 215262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'gamma-MSH' fragments from ACTH-beta-LPH precursor have an affinity for opiate receptors.
    Oki S; Nakao K; Nakai Y; Ling N; Imura H
    Eur J Pharmacol; 1980 Jun; 64(2-3):161-4. PubMed ID: 6249615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid receptors for the dynorphin peptides.
    James IF
    NIDA Res Monogr; 1986; 70():192-208. PubMed ID: 2876385
    [No Abstract]   [Full Text] [Related]  

  • 39. Some aspects of opiate receptors.
    Herz A; Schulz R; Wüster M
    Adv Biochem Psychopharmacol; 1980; 21():329-37. PubMed ID: 6246748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loperamide binding to opiate receptor sites of brain and myenteric plexus.
    Mackerer CR; Clay GA; Dajani EZ
    J Pharmacol Exp Ther; 1976 Oct; 199(1):131-40. PubMed ID: 10422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.